Bovine Spongiform Encephalopathy
FDA issues statement on new measures against BSE
Published in Health and Medicine Week, January 19th, 2004
The U.S. Food and Drug Administration (FDA) fully supports the safety policies for handling of beef products announced by the U.S. Department of Agriculture (USDA), which build on the principles and procedures that FDA and USDA have developed since 1997. These protective measures will add an additional layer of protection for the American public against bovine spongiform encephalopathy (BSE).
To attain these goals, FDA will evaluate the impact of the new policies on the agency's resources, so that it can devise and implement the most effective and efficient enforcement strategies.
FDA will take appropriate steps to provide for the proper handling of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Depression
Research reveals social isolation boosts teen girls' suicide thoughts - Acne
New drug application submitted for Actiza - Bone Health
Inhaled corticosteroids found safe - Botulinum Toxin
Electrophoresis method to evaluate botulinum toxin activity developed - Bovine Spongiform Encephalopathy
FDA issues statement on rendered products derived from BSE cow in Washington - Brain Injury
Depression, other psychiatric illnesses common following brain injury - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
